An affiliate of HIG Capital (HIG) has made a strategic equity investment in Rising Pharma Holdings and Casper Pharma (collectively, “Rising Pharmaceuticals”), a provider of generic and specialty pharmaceuticals in the United States.
Rising Pharmaceuticals develops and markets generic and specialty branded pharmaceutical products across various therapeutic categories.
HIG’s investment in the company represents its latest transaction in the pharma services sector. Other active HIG pharma services investments include Aspire Pharma, BioVectra, Leiters and Taconic BioSciences.
Read more/Source: Private Equity Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.